SKI Market

A+| A| A-|

Indian Indices

Sensex

76,847.57 -702.68
( -0.91%)

Global Indices

Nasdaq

48,242.37 304.80
(0.64%)

Dow Jones

6,907.55 69.66
(1.02%)

Hang Seng

57,815.15 1,312.38
(2.32%)

Nikkei 225

10,601.00 18.04
(0.17%)

Forex

USD-INR

93.15 0.65
(0.70%)

EUR-INR

109.13 1.08
(1.00%)

GBP-INR

125.28 1.20
(0.96%)

JPY-INR

0.58 0.00
(0.42%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gland Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

543245

INE068V01023

610.0166926

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAND

23.9

28366.11

EPS(TTM)

Face Value()

Div & Yield %

72.04

1.05

Back

Remi Edelstahl Tubulars standalone net profit declines 53.01% in the December 2025 quarter

Feb 13,2026

Net profit of Remi Edelstahl Tubulars declined 53.01% to Rs 0.39 crore in the quarter ended December 2025 as against Rs 0.83 crore during the previous quarter ended December 2024. Sales declined 20.48% to Rs 34.12 crore in the quarter ended December 2025 as against Rs 42.91 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	34.12	42.91	-20
OPM %	4.78	5.62	-
PBDT	1.29	2.23	-42
PBT	0.46	1.33	-65
NP	0.39	0.83	-53

76,847.57 -702.68 ( -0.91%)

48,242.37 304.80 (0.64%)

6,907.55 69.66 (1.02%)

57,815.15 1,312.38 (2.32%)

10,601.00 18.04 (0.17%)

93.15 0.65 (0.70%)

109.13 1.08 (1.00%)

125.28 1.20 (0.96%)

0.58 0.00 (0.42%)